SAGE - Sage Therapeutics, Inc.
8.68
-0.020 -0.230%
Share volume: 22,698,684
Last Updated: 07-30-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$8.70
-0.02
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | |
| Report Date | 04-25-2024 | 07-31-2024 | 10-29-2024 | 02-11-2025 | 04-29-2025 | 07-30-2025 | |
| Cash flow financing | 1.557 M | 8.071 M | 1.037 M | -2.000 K | 148.000 K | -65.000 K | |
| Other financing cash flows | 0.000 | 0.000 | -399.000 K | -1.000 K | -94.000 K | -65.000 K | |
| Cash flow | -37.832 M | -80.437 M | -274.000 K | -19.988 M | -35.797 M | 22.263 M | |
| Net income | -108.483 M | -102.854 M | -93.551 M | -95.778 M | -62.214 M | -49.652 M | |
| Depreciation | 336.000 K | 311.000 K | 255.000 K | 129.000 K | 112.000 K | 104.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 10.509 M | 9.943 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 139.436 M | -386.000 K | 81.054 M | 46.574 M | 45.783 M | 81.018 M | |
| Net Borrowings | -743.601 M | -675.536 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | 717.013 M | 646.793 M | -274.000 K | -19.988 M | -35.797 M | 22.263 M |